¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"radiation threshold"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • residual radiation
    ÀÜ·ù¹æ»ç¼±
  • radiation weighting factor
    ¹æ»ç¼±°¡Áß°è¼ö
  • radiation-induced
    ¹æ»ç¼±À¯¹ß-
  • radiation-induced cancer
    ¹æ»ç¼±À¯¹ß¾Ï
  • resonance radiation
    °ø¸íº¹»ç
  • scattered radiation
    »ê¶õ¹æ»ç¼±
  • ultraviolet radiation
    Àڿܼ±º¹»ç
  • whole-body radiation
    Àü½ÅÁ¶»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • ionizing radiation
    ÀÌ¿ÂÈ­¹æ»ç¼±
  • radiation injury
    ¹æ»ç¼±¼Õ»ó
  • radiation interaction
    ¹æ»ç¼±»óÈ£ÀÛ¿ë
  • radiation survey instrument
    ¹æ»ç¼±Ç¥º»Á¶»ç±â±¸
  • leakage radiation
    ´©Ãâ¹æ»ç¼±
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • multipole radiation
    ´Ù±Ø¹æ»ç¼±
  • radiation monitoring
    ¹æ»ç¼±°¨½Ã
  • radiation-induced myelopathy
    ¹æ»ç¼±À¯¹ßô¼öº´Áõ
  • natural radiation
    ÀÚ¿¬¹æ»ç¼±
  • nonionizing radiation
    ºñÀ̿¹æ»ç¼±
  • radiation necrosis
    ¹æ»ç¼±±«»ç
  • radiation nephritis
    ¹æ»ç¼±ÄáÆÏ¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • radiation induced cancer
    ¹æ»ç¼±À¯¹ß¾Ï
  • radiation injury gastrointestinal syndrome
    ¹æ»ç¼±¼Õ»óÀ§ÀåÁõÈıº(¡­êÖ ñø ý¦ÏØ).
  • radiation interaction
    ¹æ»ç¼± »óÈ£ÀÛ¿ë
  • radiation leukemia
    ¹æ»ç ¹æ»ç¼±¹éÇ÷º´(Û¯ÞÒàÊÛÜúìÜ»).
  • radiation leukemia
    ¹æ»ç¼±¹éÇ÷º´(Û¯ÞÒ Û¯ÞÒàÊÛÜúìÜ»)
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • radiation monitoring
    ¹æ»ç¼±°¨½Ã
  • radiation morbidity scoring criteria
    ¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
  • radiation mucositis
    ¹æ»ç¼±Á¡¸·¿°
  • radiation myelitis
    ¹æ»ç¼±Ã´¼ö¿°(Û¯ÞÒàÊô±âÐæú).
  • radiation myelitis
    ¹æ»ç¼±Ã´¼ö¿°(Û¯ÞÒàÊô±âÐæú)
  • radiation myelitis
    ¹æ»ç¼±Ã´¼ö¿°
  • radiation myelopathy
    ¹æ»ç¼±Ã´¼öÁõ
  • radiation necrosis
    ¹æ»ç¼± ±«»ç
  • radiation necrosis
    ¹æ»ç¼±±«»ç(Û¯ÞÒàÊÎÕÞÝ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • auditory radiation
    û¹æ»ç
  • auditory radiation
    û°¢·ÎºÎê»ì
  • background radiation
    ¹èÈĹæ»ç¼± , ¹è°æ-
  • boost radiation therapy
    Ãß°¡¹æ»ç¼±Ä¡·á
  • braking radiation
    Á¦µ¿¹æ»ç¼±, Á¦µ¿º¹»ç
  • braking radiation
    ÀúÁö ¹æ»ç¼±
  • charged particle radiation
    ÇÏÀü(´ëÀü)ÀÔÀÚ¹æ»ç¼±
  • chronic radiation dermatitis
    ¸¸¼º ¹æ»ç¼± ÇǺο°
  • computer controlled radiation therapy
    ÄÄÇ»ÅÍÁ¦¾î(ÅëÁ¦)¹æ»ç¼±Ä¡·á
  • conformal radiation therapy
    ÀÔüÁ¶Çü¹æ»ç¼±Ä¡·á
  • continuous radiation
    ¿¬¼Ó¹æ»ç¼±Á¶»ç
  • cosmic radiation
    ¿ìÁÖ¹æ»ç¼±<º¹»ç>(ÊÙËÑË×ËÛ<ËÓË×>).
  • cosmic radiation
    ¿ìÁÖ¹æ»ç¼±
  • cumulative radiation effect
    ´©Àû¹æ»ç¼±È¿°ú
  • curative radiation therapy
    Ä¡À¯Àû¹æ»ç¼±Ä¡·á, ±ÙÄ¡Àû¹æ»ç¼±Ä¡·á
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
MRT magnetic resonance tomography; maximum relaxation time; median range score; median reaction time; me...
NDT neurodevelopmental treatment; noise detection threshold; nondestructive test, nondestructive testing...
NIPTS noise-induced permanent threshold shift
OT objective test; oblique talus; occlusion time; occupational therapist, occupational therapy; ocular ...
PLST progressively lowered stress threshold
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
ANT anaerobic threshold
ETL expiratory threshold load
FTC frequency threshold curve
GST generalized seizure triggering threshold
IAT individual anaerobic threshold
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reflected radiation
    ¹Ý»ç ¹æ»ç¼±, ¹Ý»ç º¹»ç
  • saturation radiation
    Æ÷È­ Á¶»ç¹ý
    õõÈ÷ Á¶»çÇÏ¿© ÃÖ¼ÒÀÇ Àå¾Ö·Î ÃÖ´ëÀÇ È¿°ú¸¦ ¾ò´Â Á¶»ç¹ý.
  • scattered radiation
    »ê¶õ ¹æ»ç, »ê¶õ ¹æ»ç¼±
    ¹°ÁúÀ» Åë°úÇÏ´Â µ¿¾È ¹æÇâÀ» ¹þ¾î³­ ¹æ»ç¼±.
  • solar radiation
    ÅÂ¾ç ¹æ»ç¼±
  • source of radiation
    ¹æ»ç¼± ±Ù¿ø
  • ultraviolet radiation
    ÀÚ¿Ü ¹æ»ç¼±
    ž翡¼­ ¿À´Â ¿¡³ÊÁöÀÇ ÀϺηΠÇǺθ¦ Å¿ì°Å³ª ÇǺΠ¾ÏÀ» À¯¹ßÇÑ´Ù. UVA¿Í UVB µÎ °¡Áö ŸÀÔÀÌ Àִµ¥ ÇǺΠÀü¹®°¡µéÀº µÎ °¡Áö Àڿܼ±À» Â÷´ÜÇÒ ¼ö ÀÖ´Â Àڿܼ± Â÷´ÜÁ¦ »ç¿ëÀ» ±ÇÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
radiation pneumonitis Injurious effects of radiotherapy on the lungs. There are three phases in the reaction of the lungs to radiation injury: an acute phase occurring 1 to 2 months after exposure, a subacute phase 2 to 9 months after exposure, and a chronic or fibrotic phase more than 9 months after exposure. In the acute phase there is vascular damage, congestion, oedema, and mononuclear cell infiltration; in the subacute phase the alveolar walls are infiltrated with mononuclear inflammatory cells and fibroblasts; in the chronic phase, alveolar fibrosis and capillary sclerosis take place. (cecil textbook of medicine, 19th ed, p2343)
(12 Dec 1998)
radiation poisoning A systemic condition caused by substantial whole-body irradiation, seen after nuclear explosions or accidents, rarely after radiotherapy. Manifestations depend on dose, ranging from anorexia, nausea, vomiting, and mild leukopenia, to thrombocytopenia with haemorrhage, severe leukopenia with infection, anaemia, central nervous system damage, and death.
Synonym: radiation poisoning.
(05 Mar 2000)
radiation-protective agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. Military, purposes.
(12 Dec 1998)
radiation risks The risks to health posed by exposure to radiation. Exposure comes from both natural sources and from man-made ones (medical and occupational).
See: background radiation.Because any amount of radiation may cause cellular mutations, considerable effort has been made by government and independent researchers to establish exposure guidelines. In most cases, natural sources account for the bulk of received radiation, with artificial sources adding only a small percentage to the average annual dose. Public perception of the hazards of radiation is often at odds with scientific positions on the matter. In part, equivocal research results (as in attempts to assess the added cancer risk posed by mammograms) contribute to public fears. Some psychological studies have concluded that whether or not public fears of nuclear power plants and other radiation sources are justified, the added stress caused by such fears in itself constitutes a threat to health that should be addressed.
(05 Mar 2000)
radiation-sensitizing agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
(12 Dec 1998)
radiation sickness A systemic condition caused by substantial whole-body irradiation, seen after nuclear explosions or accidents, rarely after radiotherapy. Manifestations depend on dose, ranging from anorexia, nausea, vomiting, and mild leukopenia, to thrombocytopenia with haemorrhage, severe leukopenia with infection, anaemia, central nervous system damage, and death.
Synonym: radiation poisoning.
(05 Mar 2000)
radiation therapy <radiobiology> Treatment with high energy radiation from X-rays or other sources of radiation.
(16 Dec 1997)
radiation tolerance The ability of some cells or tissues to withstand ionizing radiation without serious injury. Tolerance depends on the species, cell type, and physical and chemical variables, including radiation-protective agents and radiation-sensitizing agents.
(12 Dec 1998)
radiation weighting factor In radiation protection, a factor weighting the absorbed dose of radiation of a specific type and energy for its effect on tissue.
See: equivalent dose.
(05 Mar 2000)
gamma radiation Ionizing electromagnetic radiation resulting from nuclear processes, such as radioactive decay or fission.
(05 Mar 2000)
geniculocalcarine radiation The massive, fanlike fibre system passing from the lateral geniculate body of the thalamus to the visual cortex (striate or calcarine cortex, area 17 of Brodmann); the fibres follow the retrolenticular and sublenticular limbs of the internal capsule into the corona radiata but they curve back along the lateral wall of the temporal and occipital horns of the lateral ventricle to the striate cortex on the medial surface and pole of the occipital lobe.
Synonym: radiatio optica, geniculocalcarine radiation, geniculocalcarine tract, Gratiolet's fibres, Gratiolet's radiation, occipitothalamic radiation, Wernicke's radiation.
(05 Mar 2000)
recombination radiation <physics> Radiation produced when a free electron in a plasma is captured by an ion.
(09 Oct 1997)
Cerenkov radiation Light given off by a transparent medium when a high energy particle speeds through it at a velocity greater than that of light in that medium.
(05 Mar 2000)
characteristic radiation Monochromatic radiation that is produced when an electron is ejected from an atom and another takes its place by jumping from another shell; the energy of the photon is the difference between that of the two shell positions.
Synonym: characteristic emission.
(05 Mar 2000)
Gratiolet's radiation The massive, fanlike fibre system passing from the lateral geniculate body of the thalamus to the visual cortex (striate or calcarine cortex, area 17 of Brodmann); the fibres follow the retrolenticular and sublenticular limbs of the internal capsule into the corona radiata but they curve back along the lateral wall of the temporal and occipital horns of the lateral ventricle to the striate cortex on the medial surface and pole of the occipital lobe.
Synonym: radiatio optica, geniculocalcarine radiation, geniculocalcarine tract, Gratiolet's fibres, Gratiolet's radiation, occipitothalamic radiation, Wernicke's radiation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á